R. Caradonna

Management of non-resectable (stage III) breast cancer.

T. Cunningham, R. Sponzo, R. Antemann, 1979, International journal of radiation oncology, biology, physics.

Regional immunotherapy has a detrimental effect on the response to combined irradiation and chemotherapy in locally advanced non-small cell bronchogenic carcinoma

N. Sedransk, M. Mckneally, J. Horton, 1981, Cancer Immunology, Immunotherapy.

Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.

J. Horton, J. Ruckdeschel, S. Hillinger, 1979, Cancer treatment reports.

Combination chemotherapy with high dose Cis-diammine-dichloroplatinum (II) (CDDP), methotrexate (MTX), and bleomycin (BLEO) for epidermoid carcinoma of the head and neck

R. Caradonna, W. Paladine, Goldstein Jc, 1978 .

Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung.

M. Mckneally, J. Horton, J. Ruckdeschel, 1985, Cancer treatment reports.

Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.

E. Perez, L. Bosserman, G. Warsi, 2009, Clinical breast cancer.